Jefferies Financial Group Inc. Amgen Inc Call Options Transaction History

Jefferies Financial Group Inc.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.36 Million - $1.48 Million	4,400 Added 7.71%	61,500 $19.8 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $8.85 Million - $10.8 Million	33,700 Added 144.02%	57,100 $17.8 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $5.22 Million - $6.3 Million	19,400 Added 485.0%	23,400 $6.65 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $4.26 Million - $5.29 Million	-19,500 Reduced 82.98%	4,000 $1.08 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $8.53 Million - $10.1 Million	-39,800 Reduced 62.88%	23,500 $5.22 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $9.39 Million - $11.4 Million	41,600 Added 191.71%	63,300 $15.3 Million
Q4 2022 Sep 21, 2023	SELL	$229.03 - $291.01 $412,254 - $523,818	-1,800 Reduced 7.66%	21,700 $5.7 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $4.97 Million - $6.31 Million	21,700 New	21,700 $5.7 Million

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.